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Abstract
Background—Naltrexone (NTX) is an opioid antagonist indicated for the treatment of
alcoholism, which is not universally effective. Thus, identifying individual predictors of NTX’s
behavioral effects is critical to optimizing its therapeutic use. Moreover, given the high rate of
relapse during treatment for alcoholism, understanding NTX’s behavioral effects when combined
with moderate ethanol intake is important. Our previous study of abstinent alcoholics and control
subjects showed that a more internal Locus of Control score predicted increased impulsive choice
on NTX (Mitchell et al., 2007). Here we tested whether this predictive relationship remains in the
context of moderate alcohol intake.
Methods—In the present study we tested the effect of acute NTX (50mg) on impulsive choice,
motor inhibition, and attentional bias after ingestion of moderate ethanol (~0.3g/kg, n = 30
subjects). Subjects included those recruited from a pool of ~1200 UC Berkeley undergraduates on
the basis of scores on the Barratt Impulsiveness Scale (BIS).
Results—Impulsive choice was positively correlated with breath alcohol concentration in
placebo sessions. Locus of Control was again the sole predictor of NTX’s effect on decision-
making among subjects with a family history of alcoholism. We also found a weak interaction
between BIS scores and NTX’s effect on impulsive choice.
Conclusions—Our results reinforce the predictive relationship between Locus of Control and
NTX’s effect on decision-making in those with a family history of alcoholism, suggesting a
possible biological basis to this relationship.
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Naltrexone (NTX), an opioid antagonist, is approved by the U.S. Food and Drug
Administration for treating alcoholism. While NTX reduces alcohol consumption in both
humans (Anton et al., 1999; Davidson et al., 1999; O’Brien et al., 1996); see (Heidbreder,
2005) for a review) and animals (Boyle et al., 1998; Stromberg et al., 1998), likely by
blocking the action of endogenous opioids, the neural mechanisms underlying NTX’s
therapeutic effect are unknown. One possibility is that NTX reduces the rewarding “high”
experienced from drinking alcohol (Sinclair, 2001; Swift et al., 1994; Volpicelli et al.,
1995). Another possibility is that, when taken with alcohol, NTX causes aversive effects,
such as nausea or dysphoria (Davidson et al., 1999; McCaul et al., 2000; Mitchell et al.,
2009; Ortner et al., 2003). NTX reduces alcohol craving and urges in abstinent alcoholics
(Anton et al 1999; Monti et al 1999; Rohsenow et al 2000; O’Malley et al 2000). Clinical
data and basic studies in animals and humans suggest that NTX may reduce impulsiveness.
For example, NTX effectively treats other impulse control disorders, such as pathological
gambling (Kim et al., 2001). In addition, rodent studies demonstrate that NTX decreases a
morphine-induced preference for small immediate rewards over larger delayed rewards
(Kieres et al., 2004). Moreover, in humans, NTX reduces preferences for immediate alcohol
consumption versus an equivalent amount of money (O’Malley et al., 2002). A laboratory
study in a sample of abstinent alcoholics and healthy moderate drinkers found that NTX had
a personality dependent effect on impulsive choice (Mitchell et al., 2007). This could
represent one mechanism by which NTX helps to reduce drinking: by helping to favor the
long-term benefits of abstinence over the short-term benefits of taking a drink of alcohol.
Moreover, the personality-dependence of this effect could contribute to the variability in
NTX’s therapeutic efficacy. Here we endeavored to test whether this personality factor,
Locus of Control, predicts NTX’s effect on impulsive choice in a larger sample in a
clinically relevant context: after consumption of a moderate dose of alcohol. When a patient
samples alcohol during NTX treatment, these “slips” less frequently precipitate a full-blown
relapse (Volpicelli et al., 1992). Although several factors could underlie this therapeutic
benefit, this finding suggests that NTX effects on decision-making may persist in the context
of moderate alcohol intake, helping to favor the long-term benefits of stopping after just one
or two drinks over the short-term benefits of subsequent drinking.
To determine whether the previously observed effect of NTX on impulsive choice remains
in humans under the influence of a moderate alcohol dose, we used a modified delay
discounting (DD) task, which allows for separate evaluation of impulsive decision-making
and motor impulsiveness. In this task, abstinent alcoholics select the smaller, sooner reward
option significantly more often than do moderate drinking control subjects (Boettiger et al.,
2007; Mitchell et al., 2005b; Mitchell et al., 2007). This tendency to choose impulsively was
positively correlated with trait impulsivity as measured by the Barratt Impulsiveness Scale
(BIS) (Mitchell et al., 2005b). Using a double-blind placebo-controlled randomized
crossover design, we tested whether impulsive choice was reduced in healthy, young adults
by a single acute dose of NTX (50 mg) when subjects were under the influence of moderate
alcohol. Our earlier study also found that NTX reduced the “mismatch” of choices in the
dominant task condition and inferred choices in a control condition (Mitchell et al., 2007).
Our previous results supported the interpretation that this effect was not due to NTX effects
on motor inhibition, but rather on attentional bias toward large monetary rewards. Thus, in
the present study, we included direct measures of motor control (Go-noGo task) and
attentional bias (dot-probe task). This allowed us to determine whether a reduction of
mismatch by NTX was attributable to improved motor inhibition or to reduced attentional
bias towards large monetary reward stimuli.
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Subjects (n=30) were recruited from the community (n=15) and from a University of
California, Berkeley (UCB; n=15) undergraduate population prescreened on the basis of
scores on the Barratt Impulsiveness Scale (BIS; (Barratt, 1994). Students in the middle,
upper, and lower 20th percentiles of BIS scores were targeted for recruitment. Student and
community participants did not differ in terms of BIS scores (t28 = 0.49, p = 0.63) and were
equally distributed across the high-impulsive and low impulsive groups (χ2(1) = 0.13, p = 1).
All subjects were healthy individuals 21-35 years old with no history of alcohol or opiate
abuse, neurological disorders, current treatment for any psychological disorders, or current
psychoactive drug use, excluding nicotine, caffeine, and moderate alcohol. Subjects
provided written, informed consent, as approved by the UCB Committee for the Protection
of Human Subjects. Subjects participated in two sessions ≥96 hours apart (mean session
separation time: 13.9 days) to allow for elimination of NTX between sessions (Lee et al.,
1988; Verebey et al., 1976). Sessions spanned ~5 hrs and subjects received monetary
compensation for participating. In addition to the behavioral testing (see “Behavioral
Tasks”), during session 1, subjects completed a standard battery of questionnaires (see
“Behavioral Inventories”). Subjects were instructed to abstain from alcohol and unnecessary
medications for 24 hours prior to each session, and to eat a low fat, light meal approximately
one hour before arriving. Upon arrival, subjects were screened for alcohol use via
breathalyzer (FC-10, Lifeloc Inc., Wheat Ridge, CO) and for psychoactive drug use via
urine screen (Biotechnostix Inc., Markham, ON). A non-zero breath alcohol concentration
(BrAC) was grounds for exclusion, as was a sample positive for cocaine, amphetamine,
methamphetamine/MDMA, or opiates. Due to the long half-life of THC, urine samples
positive for THC (n = 1) were not considered grounds for exclusion.
Naltrexone administration
Following screening for contraindications for NTX and ethanol, including a urine pregnancy
test for females, subjects were administered either a 50mg NTX capsule or an identical
placebo capsule. Capsule order was counter balanced across subjects and double blinded.
During session one, participants filled out a series of questionnaires, and then relaxed until
the alcoholic drink was administered. Following the protocol of (Mitchell et al., 2007),
administration of behavioral testing began approximately 3 hours following capsule
ingestion. This interval was selected to minimize acute physiological effects of NTX during
testing, while still achieving significant opioid receptor blockade (Atkinson, 1984; King et
al., 1997; Swift et al., 1994).
Ethanol administration
Two and a half hours following capsule ingestion, subjects commenced a 15 minute alcohol
drinking interval. The alcohol drink was prepared immediately prior to consumption and
consisted of 190 proof U.S.P. ethyl alcohol (0.3g/kg of body weight) diluted 1:5 in fruit
juice (Capri Sun, Kraft Foods, Northfield, IL). The drink was consumed in 3 equal parts, and
subjects were allowed 5 minutes to consume each third, although in practice most took only
1 of the 5 allotted minutes. BrAC values were measured via breathalyzer 30 minutes after
the onset of the drinking interval, and behavioral testing commenced thereafter.
Behavioral Inventories
We administered a number of standard questionnaires to quantify personal history and
behavioral traits that could impact our results. We quantified alcohol use behavior with the
Alcohol Use and Disorders Identification Test (AUDIT; (Saunders et al., 1993) and drug and
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alcohol use behavior with the Drug Use Screening Inventory, Domain I (DUSI-I; (Tarter,
1990). DUSI-I scores are reported in terms of the percent of affirmative answers from
Domain I, part B. We calculated density of familial alcohol abuse using the Family Tree
Questionnaire (FTQ; (Mann et al., 1985). Gambling habits were assessed with the South
Oaks Gambling Screen (SOGS; (Lesieur and Blume, 1987). Neuropsychological
questionnaires included the Barratt Impulsiveness Scale-11 (BIS; (Barratt, 1994), the Beck
Depression Inventory (BDI; (Beck and Steer, 1987), Rotter’s Locus of Control Scale (LOC;
(Rotter, 1966), the Future Time Perspective Inventory (FTPI; (Wallace, 1956), the State-
Trait Anxiety Inventory (STAI; (Spielberger, 1985), and the Antisocial Practices Scale
(ASP) of the Minnesota Multiphasic Personality Inventory 2 (MMPI-2; (Butcher JN, 1990).
Education and occupation were quantified with the Hollingshead Socioeconomic Status
(SES) score (Hollingshead, 1975). We estimated general intellectual function with the
Shipley Institute of Living Scale (SILS; (Zachary, 1991).
Behavioral Tasks
Delay Discounting Task—The paradigm was based on a previously described task
(Mitchell et al., 2005a; Mitchell et al., 2007). Briefly, in each session, subjects completed a
short (~4 min) practice run and then 8 full runs of approximately 42 or 43 trials each (~7
min). There were four trial types or cues: WANT (W), DON’T WANT (DW), SOONER,
and LARGER (together: CON for control conditions; see Figure 1A). Trials were randomly
ordered and weighted so that half of trials were the W condition and the rest were evenly
split between the other three conditions. Each trial began with an instruction cue, followed
by two options (see Figure 1B), each consisting of a monetary value and a time. Subjects
were asked to evaluate the choices as if they would actually receive the specified amounts at
the corresponding times. In each trial, one of the options consisted of one of five “full”
amounts ($2, $5, $10, $20, or $100) and one of five future delays (1 week, 2 weeks, 1
month, 3 months, or 6 months). The other option included a discounted amount (70, 85, 90,
or 95% of the “full” amount) always offered with no delay (”TODAY”).
Subjects were instructed to make a choice in each trial, according to the trial type. They
were to select their preferred option on W trials, their non-preferred option on the DW trials,
and the side with the sooner time or larger amount of money for SOONER and LARGER
(CON) trials, respectively. These control trials verified that subjects understood the task and
maintained attention. The order of trial types was the same for all subjects; however, the
delayed amount, delay time, and discount were selected from a randomly ordered list.
Hypothetical rewards were used rather than actual money based on results from comparison
studies (Critchfield and Kollins, 2001; Johnson and Bickel, 2002; Lagorio and Madden,
2005; Madden et al., 2003; Madden et al., 2004).
Go-NoGo Task—Subjects also completed a Go-NoGo task, which allowed direct
measurement of the effect of NTX on motor inhibition. The “Go” stimulus was “$70”, in the
same font and size as the stimuli used in the delay discounting task. The “NoGo” stimulus
was an identically formatted and positioned “$100”. On each trial, stimuli appeared on the
screen for 700 ms followed by a blank screen for 300 ms. Subjects completed two runs of 80
trials each, with 15% NoGo trials, presented in pseudorandom order.
Dot-probe Task—To measure NTX’s effect on attentional bias, subjects performed a dot-
probe type task (MacLeod et al., 1986). The stimuli mimicked the options screen of the
delay discounting task (excluding the instruction cue). For each trial, the two stimuli
appeared on either side of a fixation cross for 500 ms. The stimuli then disappeared and each
was replaced by a target (two dots) or non-target (one dot). Subjects pressed a button to
indicate the side of the target stimulus. To quantify attentional bias towards the larger
Altamirano et al. Page 4













amount we calculated the following reaction time (RT) bias index from correct trials: RTS –
RTL, where RTS indicates the mean RT for trials in which the target appears on the side
with the smaller amount, and RTL indicates the mean RT for trials in which the target
appeared on the side with the larger amount. Using this measure, positive values indicate
faster responses to targets cued by the larger amounts, which reflects attentional bias to the
larger amounts. During each session, subjects completed one run of 80 trials. For all but four
subjects, the delay discounting task preceded the dot probe task.
Data Analysis
Our index of temporal discounting was the proportion of earlier choices, which we have
termed the impulsive choice ratio (ICR). This value was calculated across all W trials, as
well as separated according to delay time and delayed amount. On DW trials, inferred ICR
(iICR) was calculated based on the non-selected value for each delay time. As a gross index
of motor control, “motor mismatch” (MM) was calculated as the absolute difference
between ICR and iICR for each delay time, averaged across all delay times.
To test the significance of across group comparisons, we used unpaired two-tailed t-tests for
continuous measures and χ2 tests for categorical measures. For multi-factorial comparisons,
mixed repeated measures ANOVAs in SPSS were used, with group as a between subjects
factor. When necessary, a Greenhouse-Geisser non-sphericity correction was applied. Post-
hoc paired comparisons were performed where indicated using two-tailed t-tests. When data
were not normally distributed, appropriate arcsine-root transformations were applied in
Excel prior to making statistical comparisons to ensure the validity of parametric statistical
tests. Simple regression analysis and analyses of covariance (ANCOVA) were performed in
SPSS. To estimate which continuous variables had the greatest predictive value for the NTX
effects on ICR and MM, linear multiple regression analyses were carried out using SPSS.
For each multiple regression analysis, we entered variables stepwise, divided into five
blocks. The blocks were as follows: block 1 - age, gender, ethnic group, years of education,
HH-SES-self, HH-SES-parent, IQ, body mass index (BMI); block 2 – AUDIT, FTQ density,
DUSI; block 3 – BIS, BDI, SOGS, LOC, APS, FTPI-I-mean extension, FTPI-I-max
extension, FTPI-2-mean extension, STAI-State, STAI-Trait; block 4 – peak BrAC or change
in peak BrAC; EtOH metabolism rate or change in EtOH metabolism rate; block 5 – WANT
(or DW) trial RT or RT change, Go-NoGo false alarms (FA) or FA change, dot probe RT
difference or RT difference change.
RESULTS
Demographic and psychometric data
We previously found that BIS scores positively correlate with ICR (Mitchell et al., 2005b)
and that abstinent alcoholics score significantly higher on the BIS relative to controls
(Mitchell et al., 2005b; Mitchell et al., 2007). Here we tested whether BIS scores predicted
ICR differences in a sample with high variance in BIS scores, but no history of substance
use disorders. We divided subjects into two groups based on a median split of Barratt
Impulsiveness Scale (BIS) scores. There were no significant differences between the two
groups in terms of age, education, socioeconomic status (SES), gender, ethnicity, family
history of alcohol abuse (FTQ density), orientation towards the future (FTPI), locus of
control (LOC) or gambling history (SOGS; see Table 1). The more impulsive group (High
Imp) did however, report slightly greater depression (BDI), trait anxiety (STAI-T), alcohol
use (AUDIT), and endorsed more positive answers on the Drug Use Screening Inventory,
part IB (DUSI-I B) than did the low impulsive group (Low Imp).
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Factors predicting impulsive choice tendency in the presence of alcohol
In the placebo session, the High Imp group tended to select the smaller, sooner reward more
frequently (ICR: 0.40 ± .33) than did the Low Imp group (0.39 ± .38); however, this
difference did not reach statistical significance (p = 0.79). A simple regression analysis also
failed to find a significant relationship between BIS scores and ICR (p = 0.63). To identify
factors that did predict ICR in the context of moderate alcohol consumption, we performed a
multiple regression analysis of placebo session ICR data that identified two factors that
predicted impulsive choice tendencies: future orientation (as measured by FTPI part 1 max)
and peak BrAC (Table 2; Fig. 2A,B). ICR was negatively correlated with future-orientation
and positively associated with BrAC. This latter correlation indicates that moderate EtOH
intake increases impulsive choices, although the mean placebo ICR we observed here (0.39)
was similar to that observed in other samples with no history of substance use disorders and
not under the influence of EtOH (0.3-0.4) (Boettiger et al., 2007; Mitchell et al., 2005b;
Mitchell et al., 2007).
Acute effects of NTX after moderate alcohol intake
In the delay discounting task, a mixed-model ANOVA revealed a significant main effect of
trial type on RT, but no significant main effects of trait impulsiveness group or drug
condition, nor any significant interaction between these factors (Table 3). These data are
consistent with those found previously (Mitchell et al., 2005b; Mitchell et al., 2007), and
indicate that NTX effects on RT are not altered by the presence of moderate alcohol. We
found no main effect of NTX on ICR, however there was a significant drug × group
interaction (F1,28 = 5.314, p=0.029; Fig. 3). Post hoc tests suggest that this effect was driven
by a trend for less impulsive decisions in the Low Imp group on NTX (t14 = 1.93, p = 0.07).
These results indicate that NTX does not have uniform effects on decision-making behavior
in the context of moderate alcohol intake.
In our previous laboratory study, we found NTX to significantly reduce MM in our task
(Mitchell et al., 2007). Contrary to our expectation, we found that under the influence of
moderate alcohol, NTX failed to reduce MM (F1,28 = 0.05, p=0.82). We also found no
significant drug × impulsivity group interaction (F1,28 = 0.22, p=0.64). Thus, moderate
alcohol appears to occlude NTX’s effect on MM. The Go-NoGo and dot-probe tasks were
included as a means to dissociate expected NTX effects on MM into motor control and
attentional bias factors. Given that we did not detect a significant reduction in MM on NTX,
this need was eliminated. We also found that NTX had no effect on motor inhibition in the
Go-NoGo task or attentional bias in the dot-probe task (maximum F = 3.1).
Factors predicting NTX effect on impulsive choice in the presence of alcohol
In our previous laboratory study of the effects of NTX on delay discounting, we found that a
single factor held significant predictive value: Rotter’s Locus of Control (LOC) scores; this
relationship was particularly strong in subjects with a history of alcohol use disorder
(Mitchell et al., 2007). Here, we again used multiple linear regression to identify any
demographic or psychometric measures that had significant predictive value in terms of the
NTX effect on ICR. No variable held significant predictive value in the whole sample.
However, our previous finding was derived from a sample in which 83% of participants
reported a positive family history of alcohol abuse (FHP) (Mitchell et al., 2007). Thus, we
repeated the multiple linear regression procedure including only data from FHP subjects
(n=15). Within the FHP group, we found that a single variable, LOC score, again
significantly predicted NTX effects on ICR (p = 0.001, Figure 4; see Table 4 for complete
model). Lower LOC scores, which reflect a more internal attribution style, again predicted
an increase in ICR on NTX, whereas a more external attribution style predicted reduced ICR
on NTX.
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NTX may retard ethanol metabolism
A surprising finding in this study was a trend toward slower ethanol metabolism in NTX
than in placebo sessions (F1,26 = 3.901, p=0.059). This effect has not been reported
previously; however NTX has been reported to alter the subjective effects of alcohol,
decreasing the stimulating effects and increasing the sedating effects of alcohol compared to
placebo (Swift et al 1994). A slowing of ethanol metabolism by NTX could contribute to
changes in perceived subjective effects of ethanol. Moreover, published reports have been
based primarily on Caucasian subjects, while our subject pool was only 40% Caucasian.
DISCUSSION
Trait impulsivity, impulsive choice, and moderate alcohol
Previous research has found a correlation between delay discounting behavior and subjective
measures of trait impulsivity (Mitchell et al., 2005b; Swann et al., 2002), although this
finding is not universal (Lane et al., 2003; Mitchell, 1999). This variability may have several
causes. First, self-report measures are prone to numerous limitations (Nisbett and Wilson,
1977; Wilson and Dunn, 2004) such that these may not accurately reflect actual behavior.
That said, the measure of trait impulsivity used here, BIS score, has shown substantial
heritability (>40%) in twin studies (Seroczynski et al., 1999), supporting its validity as a
phenotypic measure of at least certain aspects of the multifaceted construct of impulsivity
(Congdon and Canli, 2005; Evenden, 1999). Second, different methods have been used to
measure delay discounting. The one used here shows high test-re-test reliability (Smith et
al., personal communication), and demonstrated significant correlation with BIS scores in a
previous study (Mitchell et al., 2005b). Thus, we expected to replicate that finding here.
However, while BIS scores were collected when subjects were sober, delay discounting was
measured following moderate alcohol intake. Although impulsiveness under the influence of
moderate ethanol has not been extensively studied, some studies have found increased
impulsive choice (Petry, 2001), while others have not (Ortner et al., 2003; Richards et al.,
1999). Here we found that the BrAC achieved by the single alcohol dose was positively
correlated with impulsive choice, supporting the idea that ethanol concentration influences
promotes the tendency to choose immediate over delayed rewards. This effect may have
occluded the relationship between trait impulsivity and delay-discounting observed under
sober conditions.
Motor mismatch: occlusion of NTX effect by moderate ethanol
Based on our earlier finding that NTX significantly reduced MM, we were surprised to find
a lack of effect here. The average MM scores in placebo sessions (~0.1) were nearly
identical to those seen in control subjects in two previous studies (Mitchell et al., 2005b;
Mitchell et al., 2007), and the range of MM scores was also the same. The simplest
explanation is that alcohol is occluding the effect of NTX on MM, but the question arises:
Which system is mediating this effect? Two conditions must be met. First, the function of a
candidate system must be altered by NTX. Second, alcohol intake must independently alter
this same system. Although alcohol elicits endogenous opioid release (Gianoulakis, 1993),
which would be the first system to consider, NTX would block any effect of such release
(Herz, 1997). Thus, MM is not likely to result from elevated endogenous opioid signaling. A
second candidate system regulating MM is the dopamine (DA) system. NTX can indirectly
reduce DA release in striatal targets (Fields et al., 2007; Herz, 1997; Herz, 1995; Spanagel et
al., 1992), a possible mechanism underlying its ability to reduce MM. In contrast, acute
ethanol potently enhances DA release in the striatum (Herz, 1997). Thus, these two
opposing actions on the DA system could underlie the lack of an effect of NTX on MM
observed in the present study. One hypothesis generated by this interpretation is that high
levels of baseline DA signaling should be associated with higher levels of MM. Support for
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this hypothesis comes from our previous data showing significantly less MM in people with
a history of alcoholism (Mitchell et al., 2007), a group reported to exhibit depressed levels
of striatal DA (Volkow et al., 2007). Future investigations using genetic methods to address
this question may prove illuminating.
Individual differences in NTX effects on impulsive choice: possible explanations for the
interaction between family history of alcoholism and LOC
Dopamine system—In our previous study of subjects with or without a personal history
of alcoholism, we found that LOC scores were the sole predictor of NTX’s effect on
immediate reward bias (Mitchell et al., 2007). LOC is a personality measure reflecting one’s
perception of control over life events (Rotter, 1966), and LOC scores show substantial
heritability (Miller and Rose, 1982; Pedersen et al., 1989), suggesting a biological basis.
Based on evidence that LOC scores reflect tonic frontal DA transmission (Declerck et al.,
2006) and that acute elevation of DA may reduce delay discounting (de Wit et al., 2002;
Wade et al., 2000), we reasoned that NTX may alter impulsive choice by altering the level
of tonic DA transmission in the frontal cortex (Herz, 1995; Margolis et al., 2006; Spanagel
et al., 1992). It is important to point out that NTX is an antagonist at both mu and kappa
opioid receptors, albeit with approximately 2.5-fold greater affinity for mu-opioid receptors
(Emmerson et al., 1994). A 50 mg oral dose of NTX will achieve nearly complete blockade
of mu-opioid binding sites in the human brain (Lee et al., 1988; Weerts et al., 2008). The
current lack of suitable kappa-opioid PET ligands prevents us from knowing how
completely this NTX dose blocks kappa receptors in the human brain, but we do know that
this dose blocks ~20% of delta-opioid receptors in the human brain, for which NTX has
approximately 25-fold lower affinity, relative to kappa receptors (Emmerson et al., 1994).
Thus, a 50 mg oral dose of NTX is certainly achieving very significant blockade of kappa
opioid receptor sites, which are comparable in abundance to mu-opioid receptors in the brain
(Pfeiffer et al., 1982). Furthermore, there is evidence from rodent studies that whereas mu
agonists raise dopamine levels in prefrontal cortex, kappa agonists have the opposite effect
(Herz, 1995; Margolis et al., 2006; Spanagel et al., 1992). People with a personal or family
history of alcoholism are reported to have relatively low levels of circulating endogenous
mu-opioid agonists (Dai et al., 2005; del Arbol et al., 1995; Gianoulakis et al., 1989; Govoni
et al., 1983; Vescovi et al., 1992). Therefore, we previously speculated that such individuals
would experience more of a dopamine elevating effect of NTX, due to relatively enhanced
kappa-opioid blockade effects of NTX (Mitchell et al., 2007). That speculation was
supported by our observation that the predictive relationship between LOC and NTX effects
on impulsive choice was stronger among the abstinent alcoholic subjects in our previous
study. This hypothesis is further supported by the present data showing that LOC most
strongly predicts NTX’s effect on decision-making among subjects with a family history of
alcoholism. We now expand upon our previously hypothesized model for dopaminergically
mediated effects of NTX on decision-making. First, we propose that due to opposing effects
of mu- and kappa-opioid receptors on forebrain DA release, individuals with no personal or
family history of alcoholism, NTX likely has mixed, opposing effects on frontal DA release
(Fig. 5A), with some subjects experiencing DA increases, others, DA decreases, and still
others, no net effects on DA signaling. In contrast, individuals with a family history of
alcoholism would be expected to experience relatively greater effects of kappa opioid
receptor blockade; thus, such individuals would tend to experience an elevation in frontal
DA levels in response to NTX (Fig. 5B). Dopaminergic modulation of frontal functions
often follows a U-shaped curve, where too little or too much DA causes inefficiencies in
frontal functioning (Arnsten, 1997; Williams and Castner, 2006; Zahrt et al., 1997). We
propose a U-shaped relationship between impulsive choice and frontal DA levels (Fig. 5C).
Such a model fits our experimental data (shown in Fig. 4) well, in that NTX’s effects on ICR
are reliably predicted for FHP subjects, but not for FHN subjects. One prediction of this
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model is that the effects of direct elevation of frontal DA on impulsive decision-making
should depend on baseline frontal DA levels, and effects are not expected to interact with
family history of alcoholism. Future studies will address this hypothesis.
The differential effects of NTX in FHP versus FHN subjects is potentially clinically relevant
in light of the fact that NTX appears to be more effective in reducing alcohol intake among
FHP alcoholics relative to those that are FHN (Krishnan-Sarin et al., 2007; Monterosso et
al., 2001). Here we propose that the differential effects reflect a greater effect of kappa
opioid receptor blockade by NTX in FHP subjects. In contrast, O’Malley and colleagues
have made the opposite prediction, arguing that NTX effects on alcohol intake are primarily
kappa receptor mediated in FHN alcoholics (Krishnan-Sarin et al., 2007). In this regard,
animal studies can either increase (Mitchell et al., 2005c) or decrease (Walker et al.) alcohol
consumption depending upon the behavioral state of the animal. Direct tests of these
opposing hypotheses may be possible in the future via PET imaging of NTX’s actions on
each receptor system. The availability of new, receptor-specific ligands would also allow us
to directly probe the role of each receptor subtype.
Stress system—Individuals with a family history of alcoholism experience an elevated
release of cortisol in response to acute NTX administration (King et al., 2002). Moreover,
data suggests that the HPA-axis responds differently to stress based on LOC, with an
external LOC predicting a more exaggerated cortisol release in response to stress (Bollini et
al., 2004). Thus, cortisol is a hypothetical mediator of the observed interaction between LOC
and family history of alcoholism in predicting NTX’s effects on impulsive decision-making.
The hyper-release of cortisol in response to NTX of our FHP subjects would be expected to
vary with LOC, such that in more internal individuals, cortisol goes up less than it does in
external FHP individuals. Some data support the idea that high cortisol levels reduce delay
discounting (Takahashi, 2004), which could possibly explain our observed results of reduced
discounting on NTX in external FHP subjects and increased discounting on NTX in internal
FHP subjects. It is worth noting that one primary mediator of the dysphoric effects of stress
is the kappa opioid system (Bruchas et al.). Thus, dysregulation of the stress system in FHP
subjects may well be associated with dysregulation in the kappa opioid system as well. An
up-regulation of kappa receptor signaling in FHP subjects could thus also contribute to the
scenario we propose in Figure 5B.
Summary
In conclusion, in a young, healthy control sample under the influence of moderate alcohol,
we did not find a significant correlation between trait impulsivity and the tendency to choose
impulsively. Rather, myopia for the future and peak BrAC levels best predicted increased
frequency of impulsive choices. In addition, we extend the previous finding that LOC
predicts NTX’s effect on impulsive choice, demonstrating that this relationship is also
present after moderate ethanol consumption. Again, a lower LOC, reflecting a more internal
attribution style, correlates with an increase in impulsive choice on NTX, while a more
external attribution style correlates with reduced impulsive choice on NTX. Importantly, we
have determined that this predictive relationship is found among individuals with a family
history of alcohol abuse. Trait impulsivity showed a weaker but significant interaction of
NTX’s effect on impulsive choice, with NTX more effectively reducing impulsive choices
in subjects with low trait impulsivity. Consistent with previous findings, moderate acute
ethanol intake did not grossly increase impulsive choices (Ortner et al., 2003; Petry, 2001;
Richards et al., 1999); however peak BrAC positively correlated with impulsive choice
tendency and attentional bias towards smaller, immediate rewards. These data suggest that
increasing ethanol intoxication impairs decision-making by biasing decisions toward
immediate gratification. We found that NTX fails to reduce mismatch of choices in the
Altamirano et al. Page 9













DON’T WANT condition in the presence of alcohol. Finally, we made the unexpected
finding that NTX significantly slowed ethanol metabolism. Together, the results reported
here provide new insights into possible mechanisms for NTX’s ability to reduce total
ethanol intake following moderate ethanol ingestion, and suggest several novel lines of
research in this area.
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Illustration of delay discounting paradigm. A, Depiction of the four trial types. The four trial
types included WANT (W), DON’T WANT (DW), and two controls (CON): SOONER and
LARGER. Trial ratio was 1/2 for the W condition and 1/6 each for the other three trial types.
B, The temporal sequence of events are shown for one example W trial. Illumination of a
fixation cross (“Ready”) indicated the start of each trial. The instruction cue was then
displayed for 2 s, informing the subject of the upcoming trial type. The two options were
then presented while the instruction cue remained on the screen. The choices remained on
the screen for 2 s, however subjects had a total of 6 s to indicate their choice following the
appearance of the two options.
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Factors predicting choice behavior while under the influence of alcohol. (a) Arcsine-root
transformed impulsive choice ratio (ICR) versus maximum extension time on the Future
Time Perspective Inventory (FTPI; part I). (b) ICR (arcsine-root transformed) versus breath
alcohol concentration (BrAC) at the onset of behavioral testing.
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Effect of NTX on decision-making while under the influence of alcohol: interaction between
personality and drug. Average ICR (arcsine-root transformed) during placebo (PBO) and
naltrexone (NTX) sessions for low and high impulsive groups. * p < .001.
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Factors predicting NTX effect on choice behavior. Change in impulsive choice ratio (ICR;
arcsine-root transformed) versus locus of control (LOC) score for (a) all subjects and (b)
only subjects with a family history positive (FHP) for alcohol abuse. Linear fits are shown
for each set of subjects. A negative change in ICR reflects a decrease in impulsive choice
when on NTX compared to PBO.
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Model depicting opposing actions of naltrexone (NTX) on frontal dopamine (DA) levels. A,
In people family history negative (FHN) for alcoholism, mu- and kappa-opioid receptor
effects compete, and relative effects likely vary based on individual factors. B, In people
with a family history of alcoholism (FHP), kappa-opioid effects receptor effects of NTX are
predicted to dominate, elevating frontal dopamine (DA) levels. C, Impulsive choice ratios
(ICR) are postulated to depend on baseline frontal DA levels, according to a U-shaped
function. For FHP subjects, NTX elevates frontal DA, which reduces ICR in those with
external LOC scores, whereas ICR increases in those with internal LOC scores. Effects in
FHN subjects are less predictable.
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Table 1
Demographic and psychometric data
Low Imp (n = 15) High Imp (n = 15) t(28) p value
General
Age (yrs) 23 ± 4 23 ± 3 0.55 ns
Education (yrs) 16 ± 2 16 ± 2 0.00 ns
Hollingshead SES 41 ± 9 41 ± 9 0.12 ns
Gender (# female) 10 10 ns†
Ethnicity (# non-white) 8 10 ns†
Alcohol-related
AUDIT 4 ± 3 7 ± 4 2.22 0.034
DUSI-I (B) 1 ± 1 3 ± 2 2.98 0.006
FTQ density (%) 15 ± 16 15 ± 16 0.25 ns
Psychometric
Depression (BDI) 3 ± 4 7 ± 5 2.39 0.024
Impulsivity (BIS-11) 55 ± 7 74 ± 8 7.19 <0.001
Future orientation (FTPI) 33 ± 22 38 ± 17 0.72 ns
STAI – State Anxiety 29 ± 4 32 ± 8 1.33 ns
STAI – Trait Anxiety 34 ± 7 43 ± 8 3.08 0.005
Internal-External control (LOC) 11 ± 3 11 ± 4 0.39 ns
Antisocial Practices (ASP) 7 ± 4 8 ± 4 0.61 ns
Gambling (SOGS) 0.2 ± 0.6 0.2 ± 0.4 0.00 ns
Values are reported as mean ± standard deviation. Reported p-values reflect the results of unpaired two-tailed comparison between groups. Exact p-
values reported unless p < 0.001. SES, socioeconomic status; AUDIT, Alcohol Use Disorders Identification Test; DUSI-I, Drug Use Screening
Inventory, Domain I; FTQ, Family Tree Questionnaire; BDI, Beck Depression Inventory; BIS, Barratt Impulsiveness Scale-11; FTPI, Future Time
Perspective Inventory (Maximum Extension, part I); STAI, State-Trait Anxiety Inventory; LOC, Rotter’s Locus of Control Scale; ASP, Antisocial
Practices Scale of the MMPI-2; SOGS, South Oaks Gambling Screen.
†
p-value represents results of χ2 test.
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Table 2
Multiple regression analyses: factors predicting ICR under the influence of moderate alcohol (placebo
sessions)
B SE B β
Step 1
Constant 1.00 1.67
FTPI-MAX -0.01 0.004 -0.44**
Step 2
Constant 0.44 0.24
FTPI-MAX -0.01 0.004 -0.48**
Peak BrAC 18.55 6.19 0.46**
Results from Multiple Linear Regression analysis of predictors of ICR after consuming a moderate dose of EtOH (placebo sessions). B: beta value;






















CON 1554 ± 241 1620 ± 231
W 1679 ± 279 1758 ± 310
DW 1716 ± 299 1793 ± 323
High Impulsive (n=15)
CON 1639 ± 387 1617 ± 317
W 1815 ± 548 1809 ± 523
DW 1852 ± 562 1842 ± 547
Reaction times (in ms) for each trial type in the delay discounting task following placebo (PBO) or 50mg naltrexone (NTX; mean ± standard
deviation). There was a significant effect of Trial type on RT (F1,1.01, 28.4 = 22.3; p <0.001), but no significant effect of group or pill and no
significant interactions between factors (maximum F = 2.12). W, WANT trials; DW, DON’T WANT trials; CON, Control trials (SOONER &
LARGER).
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Table 4
Multiple regression analyses: factors predicting NTX effect on ICR




LOC -0.08 0.02 -0.75**
Results from Multiple Linear Regression analysis of predictors of NTX effect on impulsive choice ratio (ICR; arcsine-root transformed). B: beta
value; SE B: beta value standard error; β: standardized beta; LOC, Rotter’s Locus of Control Scale; FHP, family history positive for alcohol abuse;
**
p < .01.
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